Venus is presenting the pharmacokinetics results of VRT001-C (Oral Ceftriaxone) at the 30th European Congress of Clinical Microbiology & Infectious Diseases, Paris.

Venus is presenting the pharmacokinetics results of VRT001-C (Oral Ceftriaxone) at the 30th European Congress of Clinical Microbiology & Infectious Diseases, Paris.

VRL proudly announce to present results of plea Clinical Trial studies of its flagship product ELORES at IDWeek™ 2018, to be held on October 3-7, 2018, in San Fancisco, CA. We are happy to share that our four abstracts have been accepted for poster presentations at the IDWeek 2018.